Katja Gist
Concepts (313)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acute Kidney Injury | 101 | 2026 | 866 | 22.010 |
Why?
| | Cardiac Surgical Procedures | 28 | 2025 | 609 | 7.630 |
Why?
| | Water-Electrolyte Imbalance | 14 | 2024 | 42 | 4.380 |
Why?
| | Creatinine | 19 | 2025 | 506 | 3.540 |
Why?
| | Extracorporeal Membrane Oxygenation | 9 | 2026 | 383 | 3.460 |
Why?
| | Critical Illness | 27 | 2026 | 892 | 3.420 |
Why?
| | Postoperative Complications | 24 | 2025 | 2920 | 3.280 |
Why?
| | Renal Replacement Therapy | 19 | 2026 | 100 | 3.130 |
Why?
| | Lipocalin-2 | 6 | 2025 | 79 | 2.830 |
Why?
| | Heart Defects, Congenital | 11 | 2025 | 914 | 2.420 |
Why?
| | Water-Electrolyte Balance | 10 | 2026 | 36 | 2.290 |
Why?
| | Milrinone | 5 | 2021 | 26 | 2.270 |
Why?
| | Infant, Newborn | 59 | 2026 | 6434 | 2.200 |
Why?
| | Biomarkers | 20 | 2025 | 4275 | 1.970 |
Why?
| | Child | 77 | 2026 | 22657 | 1.920 |
Why?
| | Cardiopulmonary Bypass | 7 | 2024 | 221 | 1.900 |
Why?
| | Kidney | 16 | 2025 | 1496 | 1.850 |
Why?
| | Norwood Procedures | 4 | 2024 | 29 | 1.810 |
Why?
| | Peritoneal Dialysis | 3 | 2020 | 100 | 1.660 |
Why?
| | Chlorides | 3 | 2020 | 142 | 1.630 |
Why?
| | Retrospective Studies | 69 | 2026 | 17101 | 1.610 |
Why?
| | Infant | 47 | 2026 | 10039 | 1.590 |
Why?
| | Risk Factors | 38 | 2026 | 10792 | 1.440 |
Why?
| | Furosemide | 4 | 2025 | 37 | 1.430 |
Why?
| | Child, Preschool | 40 | 2026 | 11799 | 1.350 |
Why?
| | Hypertension | 3 | 2026 | 1264 | 1.320 |
Why?
| | Humans | 136 | 2026 | 144957 | 1.310 |
Why?
| | Arterial Switch Operation | 2 | 2020 | 15 | 1.290 |
Why?
| | Hypoplastic Left Heart Syndrome | 3 | 2018 | 120 | 1.250 |
Why?
| | Prospective Studies | 23 | 2025 | 7997 | 1.190 |
Why?
| | Male | 78 | 2026 | 72406 | 1.120 |
Why?
| | Intensive Care Units, Pediatric | 12 | 2026 | 285 | 1.090 |
Why?
| | Heart Diseases | 3 | 2025 | 350 | 1.070 |
Why?
| | Female | 75 | 2026 | 78376 | 1.020 |
Why?
| | Hospital Mortality | 13 | 2024 | 1031 | 1.020 |
Why?
| | Anticoagulants | 4 | 2025 | 724 | 0.960 |
Why?
| | Hypoxia-Ischemia, Brain | 2 | 2024 | 47 | 0.950 |
Why?
| | Acute Lung Injury | 2 | 2026 | 303 | 0.920 |
Why?
| | Citric Acid | 1 | 2025 | 34 | 0.910 |
Why?
| | Sepsis | 3 | 2024 | 641 | 0.890 |
Why?
| | Renal Insufficiency, Chronic | 4 | 2026 | 653 | 0.890 |
Why?
| | Length of Stay | 14 | 2025 | 1337 | 0.880 |
Why?
| | Chemokines, CC | 1 | 2024 | 32 | 0.870 |
Why?
| | Heart Failure | 5 | 2023 | 2323 | 0.860 |
Why?
| | Sodium Potassium Chloride Symporter Inhibitors | 1 | 2024 | 17 | 0.850 |
Why?
| | Shock, Cardiogenic | 1 | 2024 | 64 | 0.830 |
Why?
| | Infant, Premature, Diseases | 1 | 2025 | 111 | 0.830 |
Why?
| | Respiration, Artificial | 13 | 2026 | 708 | 0.810 |
Why?
| | Adolescent | 34 | 2026 | 22453 | 0.760 |
Why?
| | Reperfusion Injury | 2 | 2022 | 300 | 0.750 |
Why?
| | Tissue Inhibitor of Metalloproteinase-2 | 3 | 2021 | 14 | 0.700 |
Why?
| | Registries | 11 | 2025 | 2385 | 0.700 |
Why?
| | Insulin-Like Growth Factor Binding Proteins | 3 | 2021 | 26 | 0.700 |
Why?
| | Critical Care | 6 | 2024 | 697 | 0.690 |
Why?
| | Cardiopulmonary Resuscitation | 2 | 2022 | 342 | 0.680 |
Why?
| | Cardio-Renal Syndrome | 2 | 2019 | 18 | 0.680 |
Why?
| | Phenotype | 3 | 2024 | 3164 | 0.670 |
Why?
| | Cystatin C | 2 | 2021 | 65 | 0.630 |
Why?
| | Diuretics | 4 | 2025 | 68 | 0.620 |
Why?
| | Glomerular Filtration Rate | 3 | 2022 | 760 | 0.610 |
Why?
| | Fontan Procedure | 2 | 2019 | 191 | 0.580 |
Why?
| | Erythropoietin | 3 | 2025 | 100 | 0.570 |
Why?
| | Aorta, Thoracic | 1 | 2021 | 286 | 0.570 |
Why?
| | Esthetics | 1 | 2018 | 41 | 0.570 |
Why?
| | Fluid Therapy | 1 | 2020 | 147 | 0.570 |
Why?
| | Cicatrix | 1 | 2018 | 69 | 0.540 |
Why?
| | Publications | 1 | 2018 | 48 | 0.540 |
Why?
| | Intensive Care Units | 9 | 2024 | 916 | 0.520 |
Why?
| | Pacemaker, Artificial | 1 | 2018 | 126 | 0.510 |
Why?
| | Vasodilator Agents | 2 | 2016 | 331 | 0.500 |
Why?
| | Treatment Outcome | 19 | 2025 | 11695 | 0.500 |
Why?
| | Renal Insufficiency | 1 | 2019 | 169 | 0.500 |
Why?
| | Jugular Veins | 2 | 2019 | 42 | 0.500 |
Why?
| | Young Adult | 22 | 2026 | 14126 | 0.500 |
Why?
| | Postoperative Care | 1 | 2018 | 288 | 0.490 |
Why?
| | Reoperation | 1 | 2019 | 631 | 0.480 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2016 | 70 | 0.460 |
Why?
| | Defibrillators, Implantable | 1 | 2018 | 382 | 0.440 |
Why?
| | Brain | 3 | 2024 | 2941 | 0.420 |
Why?
| | Heparin, Low-Molecular-Weight | 1 | 2014 | 36 | 0.420 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 1143 | 0.400 |
Why?
| | Hepatitis A Virus Cellular Receptor 1 | 3 | 2024 | 41 | 0.390 |
Why?
| | Consensus | 3 | 2024 | 489 | 0.380 |
Why?
| | Pulmonary Valve Stenosis | 1 | 2013 | 25 | 0.370 |
Why?
| | Lung | 2 | 2025 | 4109 | 0.370 |
Why?
| | Heparin | 1 | 2014 | 244 | 0.370 |
Why?
| | Neonatologists | 2 | 2026 | 9 | 0.370 |
Why?
| | Nephrologists | 2 | 2026 | 14 | 0.370 |
Why?
| | Lipocalins | 2 | 2024 | 35 | 0.370 |
Why?
| | Renal Dialysis | 4 | 2024 | 462 | 0.360 |
Why?
| | Risk Assessment | 8 | 2025 | 3676 | 0.360 |
Why?
| | Venous Thrombosis | 1 | 2014 | 195 | 0.350 |
Why?
| | Cohort Studies | 10 | 2025 | 5965 | 0.350 |
Why?
| | Quality Improvement | 4 | 2026 | 1291 | 0.350 |
Why?
| | Hypothermia, Induced | 2 | 2024 | 96 | 0.350 |
Why?
| | Magnetic Resonance Imaging | 1 | 2024 | 3869 | 0.340 |
Why?
| | Pulmonary Valve Insufficiency | 1 | 2012 | 48 | 0.340 |
Why?
| | Systemic Inflammatory Response Syndrome | 5 | 2022 | 96 | 0.340 |
Why?
| | Body Surface Potential Mapping | 1 | 2010 | 8 | 0.330 |
Why?
| | Severity of Illness Index | 7 | 2026 | 2925 | 0.330 |
Why?
| | Aspirin | 1 | 2014 | 400 | 0.330 |
Why?
| | Thrombocytopenia | 2 | 2025 | 205 | 0.330 |
Why?
| | Tachycardia, Atrioventricular Nodal Reentry | 1 | 2010 | 28 | 0.320 |
Why?
| | Quality of Life | 2 | 2023 | 3192 | 0.320 |
Why?
| | Predictive Value of Tests | 3 | 2025 | 2118 | 0.320 |
Why?
| | Incidence | 4 | 2022 | 2883 | 0.310 |
Why?
| | Intensive Care Units, Neonatal | 5 | 2024 | 279 | 0.310 |
Why?
| | Gestational Age | 6 | 2025 | 975 | 0.300 |
Why?
| | Tachycardia, Supraventricular | 1 | 2009 | 45 | 0.300 |
Why?
| | Cryosurgery | 1 | 2009 | 47 | 0.300 |
Why?
| | Heart Conduction System | 1 | 2009 | 95 | 0.300 |
Why?
| | Cardiotonic Agents | 2 | 2021 | 95 | 0.290 |
Why?
| | Models, Biological | 2 | 2019 | 1822 | 0.290 |
Why?
| | Prognosis | 6 | 2025 | 4293 | 0.290 |
Why?
| | Heart | 3 | 2022 | 636 | 0.280 |
Why?
| | Delphi Technique | 3 | 2024 | 331 | 0.270 |
Why?
| | Bronchopulmonary Dysplasia | 2 | 2023 | 410 | 0.270 |
Why?
| | Ischemia | 2 | 2022 | 421 | 0.260 |
Why?
| | Time Factors | 8 | 2022 | 7183 | 0.260 |
Why?
| | Child, Hospitalized | 3 | 2022 | 55 | 0.260 |
Why?
| | Pulmonary Artery | 1 | 2013 | 1134 | 0.250 |
Why?
| | Catheter Ablation | 1 | 2010 | 353 | 0.250 |
Why?
| | Survival Rate | 4 | 2024 | 2092 | 0.250 |
Why?
| | Age Factors | 6 | 2022 | 3335 | 0.240 |
Why?
| | Vasoconstrictor Agents | 2 | 2024 | 144 | 0.240 |
Why?
| | Heart Transplantation | 2 | 2022 | 736 | 0.240 |
Why?
| | Nephrology | 2 | 2026 | 60 | 0.230 |
Why?
| | Logistic Models | 5 | 2024 | 2119 | 0.230 |
Why?
| | Supervised Machine Learning | 1 | 2025 | 23 | 0.230 |
Why?
| | Interleukin-18 | 2 | 2024 | 235 | 0.230 |
Why?
| | Postoperative Period | 3 | 2024 | 354 | 0.220 |
Why?
| | Nomograms | 1 | 2025 | 59 | 0.220 |
Why?
| | Infant, Extremely Premature | 1 | 2025 | 67 | 0.220 |
Why?
| | Bumetanide | 1 | 2024 | 5 | 0.220 |
Why?
| | Surveys and Questionnaires | 7 | 2026 | 6053 | 0.220 |
Why?
| | Renin | 1 | 2024 | 34 | 0.210 |
Why?
| | Addison Disease | 1 | 2024 | 38 | 0.210 |
Why?
| | Comorbidity | 5 | 2022 | 1660 | 0.210 |
Why?
| | Adrenal Insufficiency | 1 | 2024 | 28 | 0.210 |
Why?
| | Bone Marrow Transplantation | 1 | 2025 | 294 | 0.210 |
Why?
| | Vasopressins | 1 | 2024 | 60 | 0.210 |
Why?
| | Acute Disease | 5 | 2023 | 1031 | 0.210 |
Why?
| | Consent Forms | 1 | 2023 | 12 | 0.210 |
Why?
| | Cardiac Output, Low | 2 | 2021 | 54 | 0.200 |
Why?
| | Global Health | 2 | 2024 | 401 | 0.200 |
Why?
| | Infant, Premature | 4 | 2024 | 611 | 0.200 |
Why?
| | Multiple Organ Failure | 1 | 2024 | 124 | 0.200 |
Why?
| | Practice Patterns, Physicians' | 2 | 2026 | 1358 | 0.190 |
Why?
| | Health Information Systems | 1 | 2022 | 16 | 0.190 |
Why?
| | Odds Ratio | 3 | 2022 | 1077 | 0.190 |
Why?
| | Hydrocortisone | 1 | 2024 | 304 | 0.180 |
Why?
| | Hydroxamic Acids | 1 | 2022 | 94 | 0.180 |
Why?
| | Forecasting | 1 | 2024 | 391 | 0.180 |
Why?
| | Machine Learning | 2 | 2025 | 587 | 0.180 |
Why?
| | Informed Consent | 1 | 2023 | 198 | 0.180 |
Why?
| | Hypernatremia | 1 | 2021 | 8 | 0.180 |
Why?
| | Proportional Hazards Models | 1 | 2025 | 1325 | 0.180 |
Why?
| | Infant, Newborn, Diseases | 1 | 2023 | 113 | 0.180 |
Why?
| | Antihypertensive Agents | 1 | 2026 | 511 | 0.180 |
Why?
| | Sodium | 1 | 2022 | 197 | 0.170 |
Why?
| | Blood Pressure | 2 | 2026 | 1769 | 0.170 |
Why?
| | ROC Curve | 4 | 2025 | 615 | 0.170 |
Why?
| | Hyponatremia | 1 | 2021 | 43 | 0.170 |
Why?
| | Hyperglycemia | 1 | 2025 | 375 | 0.170 |
Why?
| | Benzodiazepines | 1 | 2022 | 168 | 0.170 |
Why?
| | Mice, Inbred C57BL | 2 | 2022 | 5997 | 0.170 |
Why?
| | Survival Analysis | 3 | 2020 | 1385 | 0.170 |
Why?
| | Coinfection | 1 | 2022 | 141 | 0.160 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2022 | 220 | 0.160 |
Why?
| | Multivariate Analysis | 1 | 2024 | 1540 | 0.160 |
Why?
| | Adenosine Monophosphate | 1 | 2021 | 86 | 0.160 |
Why?
| | Catheters, Indwelling | 1 | 2020 | 96 | 0.160 |
Why?
| | Adult | 13 | 2025 | 40506 | 0.160 |
Why?
| | Child Development | 1 | 2025 | 484 | 0.160 |
Why?
| | Perfusion | 1 | 2021 | 250 | 0.160 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2022 | 257 | 0.160 |
Why?
| | Bicarbonates | 1 | 2020 | 45 | 0.160 |
Why?
| | Metabolic Clearance Rate | 2 | 2019 | 115 | 0.150 |
Why?
| | Aminoglycosides | 3 | 2025 | 29 | 0.150 |
Why?
| | Kidney Failure, Chronic | 1 | 2025 | 598 | 0.150 |
Why?
| | Phosphodiesterase 3 Inhibitors | 1 | 2019 | 14 | 0.150 |
Why?
| | Bioprosthesis | 1 | 2019 | 40 | 0.150 |
Why?
| | Heart Failure, Diastolic | 1 | 2019 | 24 | 0.140 |
Why?
| | Prevalence | 1 | 2026 | 2836 | 0.140 |
Why?
| | Asphyxia Neonatorum | 1 | 2018 | 18 | 0.140 |
Why?
| | Kinetics | 2 | 2024 | 1629 | 0.140 |
Why?
| | Kidney Function Tests | 1 | 2019 | 157 | 0.140 |
Why?
| | Guideline Adherence | 1 | 2023 | 589 | 0.140 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2021 | 219 | 0.140 |
Why?
| | United States | 8 | 2025 | 15988 | 0.140 |
Why?
| | Recurrence | 2 | 2019 | 1135 | 0.130 |
Why?
| | Echocardiography | 3 | 2019 | 652 | 0.130 |
Why?
| | Heart Valve Diseases | 1 | 2019 | 151 | 0.130 |
Why?
| | Anti-Bacterial Agents | 2 | 2025 | 1915 | 0.130 |
Why?
| | Heart Valve Prosthesis | 1 | 2019 | 134 | 0.130 |
Why?
| | Pulmonary Valve | 1 | 2019 | 101 | 0.130 |
Why?
| | Early Medical Intervention | 1 | 2018 | 61 | 0.130 |
Why?
| | Inpatients | 1 | 2022 | 546 | 0.130 |
Why?
| | Propensity Score | 1 | 2019 | 367 | 0.130 |
Why?
| | Chi-Square Distribution | 2 | 2021 | 529 | 0.130 |
Why?
| | Brain Diseases | 1 | 2018 | 153 | 0.130 |
Why?
| | Fibroblast Growth Factors | 1 | 2018 | 188 | 0.130 |
Why?
| | Follow-Up Studies | 4 | 2025 | 5417 | 0.130 |
Why?
| | Pain | 1 | 2022 | 782 | 0.120 |
Why?
| | Cell Cycle Checkpoints | 1 | 2017 | 99 | 0.120 |
Why?
| | Early Diagnosis | 1 | 2018 | 249 | 0.120 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2019 | 197 | 0.120 |
Why?
| | Immunocompromised Host | 1 | 2018 | 201 | 0.120 |
Why?
| | Research Design | 1 | 2022 | 1137 | 0.120 |
Why?
| | Thoracic Surgery | 1 | 2018 | 144 | 0.120 |
Why?
| | Pilot Projects | 2 | 2021 | 1890 | 0.120 |
Why?
| | Hemodynamics | 1 | 2021 | 1121 | 0.120 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2019 | 2032 | 0.110 |
Why?
| | Hospitalization | 3 | 2021 | 2434 | 0.110 |
Why?
| | Algorithms | 1 | 2022 | 1839 | 0.110 |
Why?
| | Cattle | 2 | 2019 | 1000 | 0.100 |
Why?
| | Hospitals, Pediatric | 3 | 2025 | 557 | 0.100 |
Why?
| | Tachycardia | 1 | 2014 | 57 | 0.100 |
Why?
| | Pediatric Obesity | 1 | 2021 | 638 | 0.100 |
Why?
| | Cross-Sectional Studies | 3 | 2022 | 5872 | 0.100 |
Why?
| | Bayes Theorem | 1 | 2015 | 433 | 0.100 |
Why?
| | Vancomycin | 2 | 2025 | 93 | 0.100 |
Why?
| | Blalock-Taussig Procedure | 1 | 2013 | 6 | 0.100 |
Why?
| | Birth Weight | 3 | 2023 | 522 | 0.100 |
Why?
| | Feasibility Studies | 1 | 2017 | 1095 | 0.090 |
Why?
| | Fetal Growth Retardation | 1 | 2018 | 587 | 0.090 |
Why?
| | Catheterization | 1 | 2013 | 183 | 0.090 |
Why?
| | Oxidative Stress | 1 | 2019 | 1339 | 0.090 |
Why?
| | Mice | 4 | 2022 | 18365 | 0.090 |
Why?
| | Animals | 6 | 2022 | 38109 | 0.090 |
Why?
| | Ventricular Function, Right | 1 | 2014 | 297 | 0.090 |
Why?
| | Organ Size | 1 | 2012 | 463 | 0.080 |
Why?
| | Coronary Angiography | 1 | 2013 | 323 | 0.080 |
Why?
| | Colorado | 2 | 2018 | 4564 | 0.080 |
Why?
| | Fluoroscopy | 1 | 2010 | 176 | 0.080 |
Why?
| | Pulmonary Embolism | 1 | 2012 | 244 | 0.080 |
Why?
| | Age Distribution | 2 | 2022 | 403 | 0.080 |
Why?
| | Professional Competence | 1 | 2010 | 98 | 0.080 |
Why?
| | Acute-Phase Proteins | 2 | 2019 | 67 | 0.070 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2017 | 1416 | 0.070 |
Why?
| | Aging | 1 | 2019 | 1966 | 0.070 |
Why?
| | Body Weight | 2 | 2025 | 978 | 0.070 |
Why?
| | Aged | 3 | 2022 | 25947 | 0.070 |
Why?
| | India | 2 | 2018 | 218 | 0.070 |
Why?
| | Canada | 2 | 2019 | 428 | 0.060 |
Why?
| | Neoplasms | 1 | 2022 | 2884 | 0.060 |
Why?
| | Platelet Count | 1 | 2025 | 96 | 0.060 |
Why?
| | Databases, Factual | 2 | 2022 | 1486 | 0.050 |
Why?
| | Body Height | 1 | 2025 | 202 | 0.050 |
Why?
| | Organ Dysfunction Scores | 1 | 2024 | 53 | 0.050 |
Why?
| | Neuroprotection | 1 | 2023 | 46 | 0.050 |
Why?
| | Parenteral Nutrition, Total | 1 | 2022 | 30 | 0.050 |
Why?
| | Potassium | 1 | 2022 | 152 | 0.050 |
Why?
| | Prostaglandins | 1 | 2021 | 94 | 0.040 |
Why?
| | Michigan | 1 | 2021 | 136 | 0.040 |
Why?
| | Educational Status | 1 | 2023 | 467 | 0.040 |
Why?
| | Confidence Intervals | 1 | 2022 | 333 | 0.040 |
Why?
| | Blood Coagulation | 1 | 2023 | 268 | 0.040 |
Why?
| | Cardiovascular Diseases | 1 | 2012 | 2171 | 0.040 |
Why?
| | Societies, Medical | 1 | 2024 | 887 | 0.040 |
Why?
| | Graft Survival | 1 | 2022 | 526 | 0.040 |
Why?
| | Fluid Shifts | 1 | 2019 | 2 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2022 | 4569 | 0.040 |
Why?
| | Matched-Pair Analysis | 1 | 2019 | 37 | 0.040 |
Why?
| | Goals | 1 | 2021 | 184 | 0.040 |
Why?
| | Monte Carlo Method | 1 | 2019 | 155 | 0.040 |
Why?
| | Term Birth | 1 | 2018 | 25 | 0.040 |
Why?
| | Sex Distribution | 1 | 2019 | 386 | 0.040 |
Why?
| | Tertiary Care Centers | 1 | 2020 | 189 | 0.040 |
Why?
| | Hepatocytes | 1 | 2019 | 224 | 0.040 |
Why?
| | Urodynamics | 1 | 2019 | 47 | 0.030 |
Why?
| | Datasets as Topic | 1 | 2018 | 122 | 0.030 |
Why?
| | Substance Abuse, Intravenous | 1 | 2019 | 128 | 0.030 |
Why?
| | Homeostasis | 1 | 2022 | 640 | 0.030 |
Why?
| | Dialysis | 1 | 2017 | 18 | 0.030 |
Why?
| | Attitude of Health Personnel | 1 | 2026 | 1186 | 0.030 |
Why?
| | North America | 1 | 2018 | 310 | 0.030 |
Why?
| | History, 20th Century | 1 | 2019 | 325 | 0.030 |
Why?
| | New Zealand | 1 | 2017 | 54 | 0.030 |
Why?
| | RNA, Viral | 1 | 2021 | 688 | 0.030 |
Why?
| | Prosthesis Design | 1 | 2019 | 357 | 0.030 |
Why?
| | Pregnancy | 2 | 2021 | 7191 | 0.030 |
Why?
| | Australia | 1 | 2017 | 286 | 0.030 |
Why?
| | Sex Factors | 1 | 2022 | 2114 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2019 | 780 | 0.030 |
Why?
| | Metabolome | 1 | 2019 | 384 | 0.030 |
Why?
| | Blood Glucose | 1 | 2025 | 2330 | 0.030 |
Why?
| | Weight Gain | 1 | 2018 | 559 | 0.030 |
Why?
| | Premature Birth | 1 | 2018 | 380 | 0.030 |
Why?
| | Middle Aged | 3 | 2022 | 35928 | 0.030 |
Why?
| | Myocardium | 1 | 2019 | 939 | 0.020 |
Why?
| | Patient Discharge | 1 | 2020 | 983 | 0.020 |
Why?
| | Metabolomics | 1 | 2019 | 727 | 0.020 |
Why?
| | Body Mass Index | 1 | 2022 | 2438 | 0.020 |
Why?
| | Energy Metabolism | 1 | 2019 | 936 | 0.020 |
Why?
| | Smoking | 1 | 2019 | 1472 | 0.020 |
Why?
| | Pulmonary Surfactants | 1 | 1993 | 102 | 0.020 |
Why?
| | Infant, Low Birth Weight | 1 | 1993 | 153 | 0.020 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 1993 | 106 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2019 | 3608 | 0.020 |
Why?
| | Diabetes Mellitus | 1 | 2019 | 1098 | 0.020 |
Why?
| | Stroke | 1 | 2019 | 1258 | 0.020 |
Why?
| | Diagnostic Imaging | 1 | 2012 | 339 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2022 | 8279 | 0.020 |
Why?
| | Electrocardiography | 1 | 2012 | 663 | 0.020 |
Why?
| | Fetal Organ Maturity | 1 | 1993 | 13 | 0.010 |
Why?
| | Placebos | 1 | 1993 | 193 | 0.010 |
Why?
| | Cerebral Hemorrhage | 1 | 1993 | 120 | 0.010 |
Why?
| | Retinopathy of Prematurity | 1 | 1993 | 179 | 0.010 |
Why?
| | Cerebral Palsy | 1 | 1993 | 132 | 0.000 |
Why?
| | Psychomotor Performance | 1 | 1993 | 328 | 0.000 |
Why?
| | Intubation, Intratracheal | 1 | 1993 | 320 | 0.000 |
Why?
| | Lung Diseases | 1 | 1993 | 787 | 0.000 |
Why?
|
|
Gist's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|